Single Peptides · Exact presentation
Ovagen · 20 mg Vial
Ovagen · 20 mg Vial is an exact single peptide or compound entry. This strength is kept separate because concentration and calculations depend on vial amount.
Educational research information for this exact variation. It is not medical advice, a prescription, or proof of regulatory approval.
Dosing & Reconstitution Guide
For a 20 mg presentation, the reference concentration of 10 mg/mL mathematically corresponds to 2 mL final volume. This is concentration math, not a universal preparation instruction; the lot CoA and documentation control. 10 mg/mL. On a U-100 syringe, 1 unit equals 0.01 mL; the amount per unit would be 0.1 mg at this concentration.
Standard / Gradual Approach (2 mL = 10 mg/mL)
The source chart summarizes “10 mcg–150 mcg” at “Daily” frequency as educational information. PeptidosRD does not convert it into a clinical recommendation; any protocol must be checked against primary studies, applicable labeling, and qualified oversight.
Standard / Gradual Approach (2 mL = 10 mg/mL)
| Week | Daily Dose (μg) | Units (per injection) (mL) |
|---|---|---|
| Weeks 1–2 | 10 μg (0.01 mg) | 0.1 units (0.001 mL) |
| Weeks 3–4 | 20 μg (0.02 mg) | 0.2 units (0.002 mL) |
| Weeks 5–6 | 50 μg (0.05 mg) | 0.5 units (0.005 mL) |
| Weeks 7–8 | 100 μg (0.1 mg) | 1 unit (0.01 mL) |
| Weeks 9–16 | 100–150 μg (0.1–0.15 mg) | 1–1.5 units (0.01–0.015 mL) |
Reconstitution Steps
For a 20 mg presentation, the reference concentration of 10 mg/mL mathematically corresponds to 2 mL final volume. This is concentration math, not a universal preparation instruction; the lot CoA and documentation control. 10 mg/mL. On a U-100 syringe, 1 unit equals 0.01 mL; the amount per unit would be 0.1 mg at this concentration.
Storage Instructions
Proper storage preserves peptide quality.
Lyophilized: Store at −20 °C (−4 °F) in dry, dark conditions; stable for 1+ year.[5]
Reconstituted: Refrigerate at 2–8 °C (35.6–46.4 °F); use within 3–4 weeks and avoid freeze–thaw.[6]
Allow vials to reach room temperature before opening to reduce condensation uptake.
How This Works
It is described as a short peptide or bioregulator with proposed tissue-signaling effects. Mechanisms and targets are often less established than for well-characterized medicines.
Potential Benefits & Side Effects
Uncertainty about identity, pharmacology, efficacy, and safety is material. A biological hypothesis should not be presented as a demonstrated benefit.
Source trail
Scientific references and source discovery
- PeptideDosages — exact Ovagen · 20 mg Vial entrysecondary-structure
- PubMed — literature search for Ovagenprimary-discovery
- ClinicalTrials.gov — study search for Ovagentrial-registry
- View Sourcesource-reference
- View Sourcesource-reference
- View Sourcesource-reference
- View Sourcesource-reference
- View Sourcesource-reference